Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Circ Res ; 125(12): 1124-1140, 2019 12 06.
Article in English | MEDLINE | ID: mdl-31665965

ABSTRACT

RATIONALE: αCGRP (α calcitonin gene-related peptide), one of the strongest vasodilators, is cardioprotective in hypertension by reducing the elevated blood pressure. OBJECTIVE: However, we hypothesize that endogenous, physical activity-induced αCGRP has blood pressure-independent cardioprotective effects in chronic hypertension. METHODS AND RESULTS: Chronically hypertensive (one-kidney-one-clip surgery) wild-type and αCGRP-/- sedentary or voluntary wheel running mice were treated with vehicle, αCGRP, or the αCGRP receptor antagonist CGRP8-37. Cardiac function and myocardial phenotype were evaluated echocardiographically and by molecular, cellular, and histological analysis, respectively. Blood pressure was similar among all hypertensive experimental groups. Endogenous αCGRP limited pathological remodeling and heart failure in sedentary, chronically hypertensive wild-type mice. In these mice, voluntary wheel running significantly improved myocardial phenotype and function, which was abolished by CGRP8-37 treatment. In αCGRP-/- mice, αCGRP treatment, in contrast to voluntary wheel running, improved myocardial phenotype and function. Specific inhibition of proliferation and myofibroblast differentiation of primary, murine cardiac fibroblasts by αCGRP suggests involvement of these cells in αCGRP-dependent blunting of pathological cardiac remodeling. CONCLUSIONS: Endogenous, physical activity-induced αCGRP has blood pressure-independent cardioprotective effects and is crucial for maintaining cardiac function in chronic hypertension. Consequently, inhibiting endogenous αCGRP signaling, as currently approved for migraine prophylaxis, could endanger patients with hypertension.


Subject(s)
Blood Pressure/physiology , Calcitonin Gene-Related Peptide/blood , Hypertension/blood , Hypertension/therapy , Physical Conditioning, Animal/methods , Physical Conditioning, Animal/physiology , Animals , Biomarkers/blood , Cells, Cultured , Chronic Disease , Hypertension/prevention & control , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Treatment Outcome
2.
PLoS One ; 10(4): e0123697, 2015.
Article in English | MEDLINE | ID: mdl-25860809

ABSTRACT

Cerebral blood flow autoregulation (CA) shifts to higher blood pressures in chronic hypertensive patients, which increases their risk for brain damage. Although cerebral vascular smooth muscle cells express the potent vasodilatatory peptides calcitonin gene-related peptide (CGRP) and adrenomedullin (AM) and their receptors (calcitonin receptor-like receptor (Calclr), receptor-modifying proteins (RAMP) 1 and 2), their contribution to CA during chronic hypertension is poorly understood. Here we report that chronic (10 weeks) hypertensive (one-kidney-one-clip-method) mice overexpressing the Calclr in smooth muscle cells (CLR-tg), which increases the natural sensitivity of the brain vasculature to CGRP and AM show significantly better blood pressure drop-induced cerebrovascular reactivity than wt controls. Compared to sham mice, this was paralleled by increased cerebral CGRP-binding sites (receptor autoradiography), significantly in CLR-tg but not wt mice. AM-binding sites remained unchanged. Whereas hypertension did not alter RAMP-1 expression (droplet digital (dd) PCR) in either mouse line, RAMP-2 expression dropped significantly in both mouse lines by about 65%. Moreover, in wt only Calclr expression was reduced by about 70% parallel to an increase of smooth muscle actin (Acta2) expression. Thus, chronic hypertension induces a stoichiometric shift between CGRP and AM receptors in favor of the CGRP receptor. However, the parallel reduction of Calclr expression observed in wt mice but not CLR-tg mice appears to be a key mechanism in chronic hypertension impairing cerebrovascular reactivity.


Subject(s)
Cerebrovascular Circulation/physiology , Hypertension/physiopathology , Receptors, Calcitonin Gene-Related Peptide/physiology , Adrenomedullin/physiology , Animals , Binding Sites , Brain/physiopathology , Calcitonin Receptor-Like Protein/genetics , Calcitonin Receptor-Like Protein/physiology , Cerebrovascular Circulation/genetics , Female , Hypertension/genetics , Mice , Mice, Inbred DBA , Mice, Transgenic , Molecular Sequence Data , Rats , Receptor Activity-Modifying Protein 1/genetics , Receptor Activity-Modifying Protein 1/physiology , Receptor Activity-Modifying Protein 2/genetics , Receptor Activity-Modifying Protein 2/physiology , Receptors, Calcitonin Gene-Related Peptide/genetics , Recombinant Proteins/genetics , Recombinant Proteins/metabolism
3.
Physiol Rep ; 1(2): e00018, 2013 Jul.
Article in English | MEDLINE | ID: mdl-24303107

ABSTRACT

Erythroblasts proliferate and differentiate in hematopoietic organs within erythroblastic islands (EI) composed of erythropoietic progenitor cells attached to a central macrophage. This cellular interaction crucially involves the erythroid intercellular adhesion molecule-4 (ICAM-4) and αv integrin. Because integrins are biologically active as α/ß heterodimers, we asked whether ß3 could be a heterodimerization partner of αv integrin in EIs. To this end we compared stress erythropoiesis driven by two different mechanisms, namely that of integrin ß3-deficient (ß3(-/-)) mice that exhibit impaired hemostasis due to platelet dysfunction with that of systemically erythropoietin-overexpressing (tg6) mice. While compared to the respective wild type (wt) controls ß3(-/-) mice had much less erythropoietic stimulation than tg6 mice ß3(-/-) blood contained more erythrocytes of a lower maturity stage. Unexpectedly, membranes of peripheral erythrocytes from ß3(-/-) mice (but not those from either wt control or from tg6 mice) contained calnexin, a chaperone that is normally completely lost during terminal differentiation of reticulocytes prior to their release into the circulation. In contrast to erythropoietin-overexpressing mice, the erythropoietic subpopulations representing orthochromatic erythroblasts and premature reticulocytes as well as the number of cells per EI were reduced in ß3(-/-) bone marrow. In conclusion, absence of integrin ß3 impairs adhesion of the latest erythroid developmental stage to the central macrophage of EIs resulting in preterm release of abnormally immature erythrocytes into the circulation.

4.
Exp Brain Res ; 207(3-4): 249-58, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20972776

ABSTRACT

Autoregulation, an important feature of the cerebral circulation, is affected in many diseases. Since genetically modified mice are a fundamental tool in biomedical research, including neuro(bio)logy also in this specie measurements of cerebral autoregulation (CA) are mandatory. However, this requires anesthesia that unfortunately significantly impacts cerebral perfusion and consequently might distort CA measurements directly or by altering arterial pCO(2). The latter can be avoided by artificial ventilation but requires several control measurements of blood gases, each consuming at least 100 µl of blood or 5% of a mouse's blood volume. To avoid such diagnostic hemorrhage, we systematically analyzed the effect of different common anesthetic protocols used for rodents in spontaneously breathing mice on CA measured with Laser speckle perfusion imaging. Halothane, Isoflurane and Pentobarbital abrogated CA and Ketamin/Xylazine as well as Chloralose had a moderate reproducibility. In contrast, the rather rarely used anesthetic Ethomidate applied in low doses combined with local anesthetics had the best reproducibility. Although with this anesthesia the lower CA limit was lower than with Ketamin/Xylazine and Chloralose as reported in the handful of papers so far dealing with CA in mice, we suggest Ethomidate as the anesthetic of choice for CA measurements in spontaneously breathing mice.


Subject(s)
Anesthesia/methods , Anesthetics/pharmacology , Cerebrovascular Circulation/drug effects , Homeostasis/drug effects , Respiratory Physiological Phenomena/drug effects , Anesthesia/standards , Animals , Cerebrovascular Circulation/physiology , Homeostasis/physiology , Mice , Mice, Inbred C57BL
5.
Blood ; 102(6): 2278-84, 2003 Sep 15.
Article in English | MEDLINE | ID: mdl-12750170

ABSTRACT

Severe elevation of red blood cell number is often associated with hypertension and thromboembolism resulting in severe cardiovascular complications. However, some individuals such as high altitude dwellers cope well with an increased hematocrit level. We analyzed adaptive mechanisms to excessive erythrocytosis in our transgenic (tg) mice that, due to hypoxia-independent erythropoietin (Epo) overexpression, reached hematocrit values of 0.8 to 0.9 without alteration of blood pressure, heart rate, or cardiac output. Extramedullar erythropoiesis occurred in the tg spleen, leading to splenomegaly. Upon splenectomy, hematocrit values in tg mice decreased from 0.89 to 0.62. Tg mice showed doubled reticulocyte counts and an increased mean corpuscular volume. In tg mice, plasma volume was not elevated whereas blood volume was up to 25% of the body weight compared with 8% in wild-type (wt) siblings. Although plasma viscosity did not differ between tg and wt mice, tg whole-blood viscosity increased to a lower degree (4-fold) than expected from corresponding hemoconcentrated wt blood (8-fold). This moderate increase in viscosity is explicable by the up to 3-fold higher elongation of tg erythrocytes at physiologic shear rates. Apart from the nitric oxide-mediated vasodilation we reported earlier, adaptation to high hematocrit levels in tg mice involves regulated elevation of blood viscosity by increasing erythrocyte flexibility.


Subject(s)
Adaptation, Physiological/physiology , Blood Viscosity/physiology , Erythropoietin/genetics , Polycythemia/physiopathology , Animals , Blood Volume/physiology , Erythrocyte Deformability/physiology , Female , Hematocrit , Hematopoiesis, Extramedullary/physiology , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Spleen/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...